Highlands Oncology opens $4 million clinical trials suite

Springdale-based cancer-care provider Highlands Oncology recently invested about $4 million in an expanded Clinical Trials Suite amid rapid growth in its clinical trials program, which has received approval to participate in first-in-human clinical trials.